Literature DB >> 32753671

Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma.

Jasper Wouters1,2, Zeynep Kalender-Atak1,2,3, Liesbeth Minnoye1,2, Katina I Spanier1,2, Maxime De Waegeneer1,2, Carmen Bravo González-Blas1,2, David Mauduit1,2, Kristofer Davie1,2, Gert Hulselmans1,2, Ahmad Najem4, Michael Dewaele5,6, Dennis Pedri1,5,6,7, Florian Rambow5,6, Samira Makhzami1,2, Valerie Christiaens1,2, Frederik Ceyssens8, Ghanem Ghanem4, Jean-Christophe Marine5,6, Suresh Poovathingal1, Stein Aerts9,10.   

Abstract

Melanoma cells can switch between a melanocytic and a mesenchymal-like state. Scattered evidence indicates that additional intermediate state(s) may exist. Here, to search for such states and decipher their underlying gene regulatory network (GRN), we studied 10 melanoma cultures using single-cell RNA sequencing (RNA-seq) as well as 26 additional cultures using bulk RNA-seq. Although each culture exhibited a unique transcriptome, we identified shared GRNs that underlie the extreme melanocytic and mesenchymal states and the intermediate state. This intermediate state is corroborated by a distinct chromatin landscape and is governed by the transcription factors SOX6, NFATC2, EGR3, ELF1 and ETV4. Single-cell migration assays confirmed the intermediate migratory phenotype of this state. Using time-series sampling of single cells after knockdown of SOX10, we unravelled the sequential and recurrent arrangement of GRNs during phenotype switching. Taken together, these analyses indicate that an intermediate state exists and is driven by a distinct and stable 'mixed' GRN rather than being a symbiotic heterogeneous mix of cells.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32753671     DOI: 10.1038/s41556-020-0547-3

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.213


  66 in total

Review 1.  Cancer stem cells versus phenotype-switching in melanoma.

Authors:  Keith S Hoek; Colin R Goding
Journal:  Pigment Cell Melanoma Res       Date:  2010-08-20       Impact factor: 4.693

2.  Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature.

Authors:  Keith S Hoek; Natalie C Schlegel; Patricia Brafford; Antje Sucker; Selma Ugurel; Rajiv Kumar; Barbara L Weber; Katherine L Nathanson; David J Phillips; Meenhard Herlyn; Dirk Schadendorf; Reinhard Dummer
Journal:  Pigment Cell Res       Date:  2006-08

3.  A novel hypoxia-associated subset of FN1 high MITF low melanoma cells: identification, characterization, and prognostic value.

Authors:  Jasper Wouters; Marguerite Stas; Olivier Govaere; Kathleen Barrette; Aleksandra Dudek; Hugo Vankelecom; Lauren E Haydu; John F Thompson; Richard A Scolyer; Joost J van den Oord
Journal:  Mod Pathol       Date:  2014-01-03       Impact factor: 7.842

4.  Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq.

Authors:  Itay Tirosh; Benjamin Izar; Sanjay M Prakadan; Marc H Wadsworth; Daniel Treacy; John J Trombetta; Asaf Rotem; Christopher Rodman; Christine Lian; George Murphy; Mohammad Fallahi-Sichani; Ken Dutton-Regester; Jia-Ren Lin; Ofir Cohen; Parin Shah; Diana Lu; Alex S Genshaft; Travis K Hughes; Carly G K Ziegler; Samuel W Kazer; Aleth Gaillard; Kellie E Kolb; Alexandra-Chloé Villani; Cory M Johannessen; Aleksandr Y Andreev; Eliezer M Van Allen; Monica Bertagnolli; Peter K Sorger; Ryan J Sullivan; Keith T Flaherty; Dennie T Frederick; Judit Jané-Valbuena; Charles H Yoon; Orit Rozenblatt-Rosen; Alex K Shalek; Aviv Regev; Levi A Garraway
Journal:  Science       Date:  2016-04-08       Impact factor: 47.728

5.  In vivo switching of human melanoma cells between proliferative and invasive states.

Authors:  Keith S Hoek; Ossia M Eichhoff; Natalie C Schlegel; Udo Döbbeling; Nikita Kobert; Leo Schaerer; Silvio Hemmi; Reinhard Dummer
Journal:  Cancer Res       Date:  2008-02-01       Impact factor: 12.701

6.  MDM4 is a key therapeutic target in cutaneous melanoma.

Authors:  Agnieszka Gembarska; Flavie Luciani; Clare Fedele; Elisabeth A Russell; Michael Dewaele; Stéphanie Villar; Aleksandra Zwolinska; Sue Haupt; Job de Lange; Dana Yip; James Goydos; Jody J Haigh; Ygal Haupt; Lionel Larue; Aart Jochemsen; Hubing Shi; Gatien Moriceau; Roger S Lo; Ghanem Ghanem; Mark Shackleton; Federico Bernal; Jean-Christophe Marine
Journal:  Nat Med       Date:  2012-07-22       Impact factor: 53.440

7.  Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state.

Authors:  Annelien Verfaillie; Hana Imrichova; Zeynep Kalender Atak; Michael Dewaele; Florian Rambow; Gert Hulselmans; Valerie Christiaens; Dmitry Svetlichnyy; Flavie Luciani; Laura Van den Mooter; Sofie Claerhout; Mark Fiers; Fabrice Journe; Ghanem-Elias Ghanem; Carl Herrmann; Georg Halder; Jean-Christophe Marine; Stein Aerts
Journal:  Nat Commun       Date:  2015-04-09       Impact factor: 14.919

Review 8.  Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities.

Authors:  Florian Rambow; Jean-Christophe Marine; Colin R Goding
Journal:  Genes Dev       Date:  2019-10-01       Impact factor: 11.361

9.  Signatures of mutational processes in human cancer.

Authors:  Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Samuel A J R Aparicio; Sam Behjati; Andrew V Biankin; Graham R Bignell; Niccolò Bolli; Ake Borg; Anne-Lise Børresen-Dale; Sandrine Boyault; Birgit Burkhardt; Adam P Butler; Carlos Caldas; Helen R Davies; Christine Desmedt; Roland Eils; Jórunn Erla Eyfjörd; John A Foekens; Mel Greaves; Fumie Hosoda; Barbara Hutter; Tomislav Ilicic; Sandrine Imbeaud; Marcin Imielinski; Marcin Imielinsk; Natalie Jäger; David T W Jones; David Jones; Stian Knappskog; Marcel Kool; Sunil R Lakhani; Carlos López-Otín; Sancha Martin; Nikhil C Munshi; Hiromi Nakamura; Paul A Northcott; Marina Pajic; Elli Papaemmanuil; Angelo Paradiso; John V Pearson; Xose S Puente; Keiran Raine; Manasa Ramakrishna; Andrea L Richardson; Julia Richter; Philip Rosenstiel; Matthias Schlesner; Ton N Schumacher; Paul N Span; Jon W Teague; Yasushi Totoki; Andrew N J Tutt; Rafael Valdés-Mas; Marit M van Buuren; Laura van 't Veer; Anne Vincent-Salomon; Nicola Waddell; Lucy R Yates; Jessica Zucman-Rossi; P Andrew Futreal; Ultan McDermott; Peter Lichter; Matthew Meyerson; Sean M Grimmond; Reiner Siebert; Elías Campo; Tatsuhiro Shibata; Stefan M Pfister; Peter J Campbell; Michael R Stratton
Journal:  Nature       Date:  2013-08-14       Impact factor: 49.962

Review 10.  Intratumor and Intertumor Heterogeneity in Melanoma.

Authors:  Tomasz M Grzywa; Wiktor Paskal; Paweł K Włodarski
Journal:  Transl Oncol       Date:  2017-10-24       Impact factor: 4.243

View more
  38 in total

Review 1.  Deciphering functional tumor states at single-cell resolution.

Authors:  Rolando Vegliante; Ievgenia Pastushenko; Cédric Blanpain
Journal:  EMBO J       Date:  2021-12-17       Impact factor: 11.598

2.  AP-1 transcription factor network explains diverse patterns of cellular plasticity in melanoma cells.

Authors:  Natacha Comandante-Lou; Douglas G Baumann; Mohammad Fallahi-Sichani
Journal:  Cell Rep       Date:  2022-08-02       Impact factor: 9.995

3.  Fate mapping melanoma persister cells through regression and into recurrent disease in adult zebrafish.

Authors:  Jana Travnickova; Sarah Muise; Sonia Wojciechowska; Alessandro Brombin; Zhiqiang Zeng; Adelaide I J Young; Cameron Wyatt; E Elizabeth Patton
Journal:  Dis Model Mech       Date:  2022-09-16       Impact factor: 5.732

4.  A cellular hierarchy in melanoma uncouples growth and metastasis.

Authors:  Ignacio Bordeu; Joanna Pozniak; Ada Nowosad; Panagiotis Karras; Cecilia Pazzi; Nina Van Raemdonck; Ewout Landeloos; Yannick Van Herck; Dennis Pedri; Greet Bervoets; Samira Makhzami; Jia Hui Khoo; Benjamin Pavie; Jochen Lamote; Oskar Marin-Bejar; Michael Dewaele; Han Liang; Xingju Zhang; Yichao Hua; Jasper Wouters; Robin Browaeys; Gabriele Bergers; Yvan Saeys; Francesca Bosisio; Joost van den Oord; Diether Lambrechts; Anil K Rustgi; Oliver Bechter; Cedric Blanpain; Benjamin D Simons; Florian Rambow; Jean-Christophe Marine
Journal:  Nature       Date:  2022-09-21       Impact factor: 69.504

5.  MYBL2 accelerates epithelial-mesenchymal transition and hepatoblastoma metastasis via the Smad/SNAI1 pathway.

Authors:  Meng Wei; Ran Yang; Mujie Ye; Yong Zhan; Baihui Liu; Lingdu Meng; Lulu Xie; Min Du; Junfeng Wang; Runnan Gao; Deqian Chen; Rui Dong; Kuiran Dong
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

Review 6.  Heterogeneity in Melanoma.

Authors:  Mei Fong Ng; Jacinta L Simmons; Glen M Boyle
Journal:  Cancers (Basel)       Date:  2022-06-20       Impact factor: 6.575

7.  Interpretation of allele-specific chromatin accessibility using cell state-aware deep learning.

Authors:  Zeynep Kalender Atak; Ibrahim Ihsan Taskiran; Jonas Demeulemeester; Christopher Flerin; David Mauduit; Liesbeth Minnoye; Gert Hulselmans; Valerie Christiaens; Ghanem-Elias Ghanem; Jasper Wouters; Stein Aerts
Journal:  Genome Res       Date:  2021-04-08       Impact factor: 9.043

8.  Cooperation between melanoma cell states promotes metastasis through heterotypic cluster formation.

Authors:  Nathaniel R Campbell; Anjali Rao; Miranda V Hunter; Magdalena K Sznurkowska; Luzia Briker; Maomao Zhang; Maayan Baron; Silja Heilmann; Maxime Deforet; Colin Kenny; Lorenza P Ferretti; Ting-Hsiang Huang; Sarah Perlee; Manik Garg; Jérémie Nsengimana; Massimo Saini; Emily Montal; Mohita Tagore; Julia Newton-Bishop; Mark R Middleton; Pippa Corrie; David J Adams; Roy Rabbie; Nicola Aceto; Mitchell P Levesque; Robert A Cornell; Itai Yanai; Joao B Xavier; Richard M White
Journal:  Dev Cell       Date:  2021-09-15       Impact factor: 12.270

9.  Analysis of long and short enhancers in melanoma cell states.

Authors:  David Mauduit; Ibrahim Ihsan Taskiran; Liesbeth Minnoye; Maxime de Waegeneer; Valerie Christiaens; Gert Hulselmans; Jonas Demeulemeester; Jasper Wouters; Stein Aerts
Journal:  Elife       Date:  2021-12-07       Impact factor: 8.140

10.  CDK7 and MITF repress a transcription program involved in survival and drug tolerance in melanoma.

Authors:  Pietro Berico; Max Cigrang; Guillaume Davidson; Cathy Braun; Jeremy Sandoz; Stephanie Legras; Bujamin Hektor Vokshi; Nevena Slovic; François Peyresaubes; Carlos Mario Gene Robles; Jean-Marc Egly; Emmanuel Compe; Irwin Davidson; Frederic Coin
Journal:  EMBO Rep       Date:  2021-07-23       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.